Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
Laborie acquires exclusive Optilume license
Laborie announced that it had acquired a perpetual, exclusive license to the Optilume Urethral Drug Coated Balloon; the announcement said the acquisition followed FDA approval in early December.
2019
LABORIE agrees to acquire Clinical Innovations
Clinical Innovations signed a definitive agreement to be acquired by LABORIE Medical Technologies for an enterprise value of $525 million. The deal was expected to close in early 2020.